Study of Leuprolide Acetate Injectable Suspension in the Treatment of Central Precocious Puberty

Clinical trial NCT02452931 · COMPLETED

Trial details

NCT number: NCT02452931
Sponsor: Tolmar Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Precocious Puberty, Central

Start date: 2015-08-31
Primary completion: 2018-09-05
Enrollment: 64

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.